Virtu Financial’s IGC Pharma IGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6K | Buy |
+23,233
| New | +$6.45K | ﹤0.01% | 1494 |
|
|
2025
Q4 | – | Sell |
-89,546
| Closed | -$37K | – | 1918 |
|
|
2025
Q3 | $37K | Buy |
89,546
+42,654
| +91% | +$16.2K | ﹤0.01% | 1183 |
|
|
2025
Q2 | $14K | Buy |
+46,892
| New | +$14.1K | ﹤0.01% | 1288 |
|
|
2025
Q1 | – | Sell |
-12,196
| Closed | -$4K | – | 1664 |
|
|
2024
Q4 | $4K | Sell |
12,196
-110,864
| -90% | -$41.5K | ﹤0.01% | 1436 |
|
|
2024
Q3 | $53K | Buy |
123,060
+76,563
| +165% | +$30.7K | ﹤0.01% | 1004 |
|
|
2024
Q2 | $20K | Buy |
+46,497
| New | +$23.1K | ﹤0.01% | 1032 |
|
|
2024
Q1 | – | Sell |
-60,723
| Closed | -$17K | – | 1710 |
|
|
2023
Q4 | $17K | Sell |
60,723
-9,273
| -13% | -$2.87K | ﹤0.01% | 1341 |
|
|
2023
Q3 | $25K | Buy |
+69,996
| New | +$25K | ﹤0.01% | 979 |
|
|
2023
Q1 | – | Sell |
-65,152
| Closed | -$21K | – | 1766 |
|
|
2022
Q4 | $21K | Buy |
+65,152
| New | +$26.6K | ﹤0.01% | 1263 |
|
|
2022
Q3 | – | Sell |
-44,970
| Closed | -$24K | – | 1937 |
|
|
2022
Q2 | $24K | Buy |
44,970
+22,262
| +98% | +$14K | ﹤0.01% | 1297 |
|
|
2022
Q1 | $22K | Sell |
22,708
-16,922
| -43% | -$16.4K | ﹤0.01% | 1285 |
|
|
2021
Q4 | $39K | Buy |
39,630
+22,238
| +128% | +$29.8K | ﹤0.01% | 1399 |
|
|
2021
Q3 | $26K | Sell |
17,392
-172,901
| -91% | -$280K | ﹤0.01% | 1362 |
|
|
2021
Q2 | $312K | Buy |
+190,293
| New | +$290K | 0.03% | 701 |
|
|
2021
Q1 | – | Sell |
-21,135
| Closed | -$33K | – | 1798 |
|
|
2020
Q4 | $33K | Buy |
+21,135
| New | +$31.2K | ﹤0.01% | 1303 |
|
|
2020
Q3 | – | Sell |
-109,493
| Closed | -$66K | – | 1276 |
|
|
2020
Q2 | $66K | Buy |
+109,493
| New | +$59.4K | 0.01% | 963 |
|
|
2019
Q4 | $62K | Buy |
+98,050
| New | +$80.2K | 0.01% | 1168 |
|
|
2019
Q3 | – | Sell |
-51,898
| Closed | -$85K | – | 1594 |
|
|
2019
Q2 | $85K | Buy |
+51,898
| New | +$73.3K | 0.01% | 1155 |
|
|
2018
Q3 | – | Sell |
-44,012
| Closed | -$22K | – | 1848 |
|
|
2018
Q2 | $22K | Sell |
44,012
-21,346
| -33% | -$12.3K | ﹤0.01% | 1851 |
|
|
2018
Q1 | $37K | Buy |
65,358
+53,499
| +451% | +$43.8K | ﹤0.01% | 1758 |
|
|
2017
Q4 | $12K | Sell |
11,859
-5,427
| -31% | -$3K | ﹤0.01% | 2260 |
|
|
2017
Q3 | $6K | Buy |
+17,286
| New | +$6.4K | ﹤0.01% | 2426 |
|
Other funds holding IGC
VCM
VFT
LC
Virtu Financial's IGC Position: Q1 2026 in Review
Virtu Financial opened a new position in IGC Pharma (IGC) in Q1 2026: 23,233 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #1494 among its holdings. This is a return to the name: Virtu Financial previously reported a position in IGC as recently as Q3 2025.
Virtu Financial first reported a position in IGC in Q3 2017 and has held it in 22 quarters since. The position peaked at $312K in Q2 2021. 35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.
- Virtu Financial held 23,233 shares of IGC Pharma worth $6K as of Q1 2026.
- IGC Pharma was a new Virtu Financial position in Q1 2026.
- IGC Pharma made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1494 holding.
- Virtu Financial first reported a position in IGC Pharma in Q3 2017 and has held it in 22 quarters since.
- Virtu Financial's IGC Pharma position peaked at $312K in Q2 2021.
- 35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.
Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.